sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / AI for Drug Discovery

AI for Drug Discovery Market By Drug Type ( Small Molecule and Large Molecule), By Technology (Deep Learning, Machine Learning, and Others), By Therapeutic Area (Metabolic Diseases, Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Oncology, and Others), and By End User (Pharmaceutical Companies, Academic & Research Institutes, Biopharmaceutical Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027

  • Publish On: Sep-2019
  • Total Pages: 110
  • Report Code: FAF-23
  • Base Year: 2018
  • Format:

Industry Insights

The report covers the forecast and analysis of the AI for the drug discovery market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the AI for the drug discovery market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the AI for drug discovery market on a global level.

In order to give the users of this report a comprehensive view of the AI for drug discovery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the AI for the drug discovery market by segmenting the market based on the drug type, technology, therapeutic area, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

With giant pharma firms focusing on genetic data interpretation of patients, the market for AI for drug discovery is likely to gain traction over the forecast timeline. Understanding of the patient’s genetic profile assists in providing apt medicines as well as a medical treatment for the patients. Moreover, the computational approaches of machine learning help in analyzing genetic data of the patient and propose new drug and therapies.

Based on drug type, the market is sectored into small molecule and large molecule.  On the basis of technology, the industry is classified into deep learning, machine learning, and others. In terms of therapeutic area, the market is divided into metabolic diseases, immuno-oncology, neurodegenerative diseases, cardiovascular diseases, oncology, and others. Based on the end user, the market is segmented into pharmaceutical companies, academic & research institutes, biopharmaceutical companies, and others.

Global AI for Drug Discovery : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of AI for Drug Discovery Report:

  • AI for Drug Discovery structure: Overview, industry life cycle analysis, supply chain analysis
  • AI for Drug Discovery : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • AI for Drug Discovery size, trend, and forecast analysis
  • AI for Drug Discovery segments’ trend and forecast
  • AI for Drug Discovery ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • AI for Drug Discovery attractiveness and associated growth opportunities
  • Emerging trends in the AI for Drug Discovery .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

Global AI for Drug Discovery Market: By Drug Type Segment Analysis
• Small Molecule
• Large Molecule
Global AI for Drug Discovery Market: By Technology Segment Analysis
• Deep Learning
• Machine Learning
• Others 
Global AI for Drug Discovery Market: By Therapeutic Area Segment Analysis
• Metabolic Diseases
• Immuno-Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Oncology
• Others
Global AI for Drug Discovery Market: By End User Segment Analysis
• Pharmaceutical Companies
• Academic & Research Institutes
• Biopharmaceutical Companies
• Others
 Global AI for Drug Discovery Market: Regional Segment Analysis
• North America
o The U.S. 
o Canada
o Mexico
o Rest of North America
• Europe
o France
o The UK
o Spain
o Germany
o Italy
o Nordic Countries
? Denmark
? Finland
? Iceland
? Sweden
? Norway
o Benelux Union
? Belgium
? The Netherlands
? Luxembourg
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o New Zealand
o Australia
o South Korea
o Southeast Asia
? Indonesia
? Thailand
? Malaysia
? Singapore
? Rest of Southeast Asia
o Rest of Asia Pacific
• The Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa
• Latin America
o Brazil
o Argentina
o Rest of Latin America


List of Figures


List of Tables

Industry Major Market Players

  •  Recursion Pharmaceuticals,
  •  AstraZeneca,
  •  Astrocyte Pharmaceuticals Inc.,
  •  NeuroVive Pharmaceutical AB,
  •  twoXAR  Incorporated,
  •  Biogen,
  •  Bionure Farma,
  •  S.L.,
  •  BIOAGE,
  •  Genervon Biopharmaceuticals,
  •  LLC.,
  •  Hoffmann-La Roche Ltd.,
  •  Neuren Pharmaceuticals,
  •  Atomwise,
  •  Insilico Medicine,
  •  Silicon Therapeutics,
  •  Cloud Pharmaceuticals Inc.,
  •  Novartis Pharmaceuticals Corporation,
  •  Teva Pharmaceutical Industries Ltd.,
  •  BenevolentAI,
  •  Exscientia,
  •  Numerate,
  •  Envisagenics Inc.,
  •  Accutar Biotech.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying
have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions